ITRM20010293A1 - Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore. - Google Patents

Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore.

Info

Publication number
ITRM20010293A1
ITRM20010293A1 IT2001RM000293A ITRM20010293A ITRM20010293A1 IT RM20010293 A1 ITRM20010293 A1 IT RM20010293A1 IT 2001RM000293 A IT2001RM000293 A IT 2001RM000293A IT RM20010293 A ITRM20010293 A IT RM20010293A IT RM20010293 A1 ITRM20010293 A1 IT RM20010293A1
Authority
IT
Italy
Prior art keywords
medication
acetyl
pain
preparation
carnetina
Prior art date
Application number
IT2001RM000293A
Other languages
English (en)
Inventor
Menotti Calvani
Luigi Mosconi
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to IT2001RM000293A priority Critical patent/ITRM20010293A1/it
Publication of ITRM20010293A0 publication Critical patent/ITRM20010293A0/it
Priority to JP2002592919A priority patent/JP4287660B2/ja
Priority to MXPA03010919A priority patent/MXPA03010919A/es
Priority to PCT/IT2002/000336 priority patent/WO2002096409A1/en
Priority to US10/478,379 priority patent/US20040152781A1/en
Priority to ES02728055T priority patent/ES2290292T3/es
Priority to EP02728055A priority patent/EP1399141B1/en
Priority to SK1584-2003A priority patent/SK287559B6/sk
Priority to DK02728055T priority patent/DK1399141T3/da
Priority to PT02728055T priority patent/PT1399141E/pt
Priority to PL02367616A priority patent/PL367616A1/xx
Priority to CA2448242A priority patent/CA2448242C/en
Priority to AT02728055T priority patent/ATE374021T1/de
Priority to CZ20033220A priority patent/CZ20033220A3/cs
Priority to HU0401294A priority patent/HUP0401294A3/hu
Priority to DE60222662T priority patent/DE60222662T2/de
Priority to KR1020037015574A priority patent/KR100873748B1/ko
Publication of ITRM20010293A1 publication Critical patent/ITRM20010293A1/it
Priority to CY20071101520T priority patent/CY1107037T1/el
Priority to US12/232,945 priority patent/US20090062388A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
IT2001RM000293A 2001-05-29 2001-05-29 Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore. ITRM20010293A1 (it)

Priority Applications (19)

Application Number Priority Date Filing Date Title
IT2001RM000293A ITRM20010293A1 (it) 2001-05-29 2001-05-29 Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore.
KR1020037015574A KR100873748B1 (ko) 2001-05-29 2002-05-24 통증 예방요법용 약물의 제조를 위한 아세틸ｌ-카르니틴의 용도
DK02728055T DK1399141T3 (da) 2001-05-29 2002-05-24 Anvendelse af acetyl L-carnitin til fremstilling af et lægemiddel til forebyggende terapi af post-kirurgisk smerte
PL02367616A PL367616A1 (en) 2001-05-29 2002-05-24 Use of acetyl l-carnitine for the preparation of a medication for the preventive therapy for pain
PCT/IT2002/000336 WO2002096409A1 (en) 2001-05-29 2002-05-24 Use of acetyl l-carnitine for the preparation of a medication for the preventive therapy for pain
US10/478,379 US20040152781A1 (en) 2001-05-29 2002-05-24 Use of acetyl l-carnitine for the prepartion of a medication for the preventive therapy for pain
ES02728055T ES2290292T3 (es) 2001-05-29 2002-05-24 Uso de acetil l-carnitina para la preparacion de un medicamento para la terapia preventiva contra el dolor posquirurgico.
EP02728055A EP1399141B1 (en) 2001-05-29 2002-05-24 Use of acetyl l-carnitine for the preparation of a medication for the preventive therapy of post-surgical pain
SK1584-2003A SK287559B6 (sk) 2001-05-29 2002-05-24 Použitie acetyl L-karnitínu na prípravu liečiva na preventívnu terapiu bolesti
JP2002592919A JP4287660B2 (ja) 2001-05-29 2002-05-24 疼痛の予防療法用薬物の調製のためのアセチルｌ−カルニチンの使用
PT02728055T PT1399141E (pt) 2001-05-29 2002-05-24 ''utilização de acetil l-carnitina para a preparação de uma medicação para a terapia preventiva da dor pós-cirúrgica''
MXPA03010919A MXPA03010919A (es) 2001-05-29 2002-05-24 Uso de acetil l-carnitina para preparacion de medicamento para terapia preventiva del dolor.
CA2448242A CA2448242C (en) 2001-05-29 2002-05-24 Use of acetyl l-carnitine for the preparation of a medication for the preventive therapy for pain
AT02728055T ATE374021T1 (de) 2001-05-29 2002-05-24 Verwendung von l-azetylcarnitin zur herstellung eines medikaments zur präventiven post- chirurgischen schmerzbehandlung
CZ20033220A CZ20033220A3 (en) 2001-05-29 2002-05-24 Use of acetyl l-carnitine for the preparation of a medication for the preventive therapy of post-surgical pain
HU0401294A HUP0401294A3 (en) 2001-05-29 2002-05-24 Use of acetyl l-carnitine for the preparation of a pharmaceutical composition for the preventive therapy for pain
DE60222662T DE60222662T2 (de) 2001-05-29 2002-05-24 Verwendung von l-azetylcarnitin zur herstellung eines medikaments zur präventiven post-chirurgischen schmerzbehandlung
CY20071101520T CY1107037T1 (el) 2001-05-29 2007-11-28 Χρηση ακετυλ l-καρνιτινης για την παρασκευη ενος φαρμακου για την προληπτικη αγωγη του μετεγχειρητικου πονου
US12/232,945 US20090062388A1 (en) 2001-05-29 2008-09-26 Use of acetyl L-carnitine for the preparation of a medication for the preventive therapy for pain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001RM000293A ITRM20010293A1 (it) 2001-05-29 2001-05-29 Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore.

Publications (2)

Publication Number Publication Date
ITRM20010293A0 ITRM20010293A0 (it) 2001-05-29
ITRM20010293A1 true ITRM20010293A1 (it) 2002-11-29

Family

ID=11455557

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2001RM000293A ITRM20010293A1 (it) 2001-05-29 2001-05-29 Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore.

Country Status (18)

Country Link
US (2) US20040152781A1 (it)
EP (1) EP1399141B1 (it)
JP (1) JP4287660B2 (it)
KR (1) KR100873748B1 (it)
AT (1) ATE374021T1 (it)
CA (1) CA2448242C (it)
CY (1) CY1107037T1 (it)
CZ (1) CZ20033220A3 (it)
DE (1) DE60222662T2 (it)
DK (1) DK1399141T3 (it)
ES (1) ES2290292T3 (it)
HU (1) HUP0401294A3 (it)
IT (1) ITRM20010293A1 (it)
MX (1) MXPA03010919A (it)
PL (1) PL367616A1 (it)
PT (1) PT1399141E (it)
SK (1) SK287559B6 (it)
WO (1) WO2002096409A1 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040606A1 (it) 2004-12-13 2005-03-13 Sigma Tau Ind Farmaceuti Uso della acetil l-carnitina per il trattamento della sindrome fibromialgica.
JP5685362B2 (ja) * 2005-04-26 2015-03-18 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニＳｉｇｍａ−Ｔａｕ Ｉｎｄｕｓｔｒｉｅ Ｆａｒｍａｃｅｕｔｉｃｈｅ Ｒｉｕｎｉｔｅ Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ 有痛性末梢糖尿病性神経障害の予防のためのアセチルｌ−カルニチン
EP4364730A1 (en) 2022-11-02 2024-05-08 Chiesi Italia S.p.A. Pharmaceutical composition comprising l-acetyl carnitine and beta-caryophyllene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0150688B1 (en) * 1983-12-28 1987-04-22 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same
IT1196564B (it) * 1986-08-04 1988-11-16 Sigma Tau Ind Farmaceuti Impiego di acetil l-carnitina nel trattamento terapeutico delle neuropatie periferiche
IT1277147B1 (it) * 1995-01-20 1997-11-04 Sigma Tau Ind Farmaceuti Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi.

Also Published As

Publication number Publication date
KR20040003030A (ko) 2004-01-07
CA2448242A1 (en) 2002-12-05
CZ20033220A3 (en) 2004-06-16
SK15842003A3 (sk) 2004-06-08
JP4287660B2 (ja) 2009-07-01
PT1399141E (pt) 2007-11-16
DE60222662T2 (de) 2008-06-26
HUP0401294A3 (en) 2008-04-28
SK287559B6 (sk) 2011-02-04
ITRM20010293A0 (it) 2001-05-29
US20040152781A1 (en) 2004-08-05
ATE374021T1 (de) 2007-10-15
EP1399141A1 (en) 2004-03-24
CA2448242C (en) 2011-01-11
DE60222662D1 (de) 2007-11-08
KR100873748B1 (ko) 2008-12-12
EP1399141B1 (en) 2007-09-26
HUP0401294A2 (hu) 2004-12-28
JP2004532865A (ja) 2004-10-28
CY1107037T1 (el) 2012-09-26
ES2290292T3 (es) 2008-02-16
US20090062388A1 (en) 2009-03-05
WO2002096409A1 (en) 2002-12-05
PL367616A1 (en) 2005-03-07
DK1399141T3 (da) 2008-01-02
MXPA03010919A (es) 2004-02-27

Similar Documents

Publication Publication Date Title
MY127290A (en) New use of flibanserin
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
HUP0104318A2 (hu) cGMP PDE-5 inhibitort tartalmazó szabályzottan hatóanyagot felszabadító gyógyászati készítmények
NO20034863L (no) Deutererte 3-piperidinopropiofenon så vel som legemidler som inneholder disse forbindelser
BR0211063A (pt) Sais de derivados anticonvulsivantes
SE0102440D0 (sv) New compound
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
ITRM20010293A1 (it) Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore.
ITRM20020492A0 (it) Uso della propionil l-carnitina per la preparazione di un medicamentoper il trattamento del glaucoma.
CY1106129T1 (el) Κιταλοπραμη για την αγωγη της υψηλης πιεσεως του αιματος
PL367628A1 (en) Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia
ITRM20000688A0 (it) Uso della isovaleril l-carnitina per la preparazione di un medicamento per la prevenzione e cura dell'osteoporosi.
ITMI20011628A1 (it) Uso della nac per la preparazione di un medicamento adatto allasomministrazione endovenosa per il trattamento del fenomeno di
ITRM20010319A1 (it) Uso di una alcanoil l-carnitina per la preparazione di un medicamentoper il trattamento dell'anedonia.